Evias is a Turkish startup founded in 2013 with a mission to revolutionize the pharmaceutical industry's research and development process. The company's slogan, "The pharmaceutical industry's research and development process is crucial for creating new medications and therapies," reflects its commitment to innovation in healthcare. Evias focuses on Digital Health, Health Care, Health and Wellness, and Healthtech industries, aiming to address the most crucial unmet medicinal needs of patients through cutting-edge science.
The startup's description emphasizes its reliance on advanced science and innovative technologies to solve healthcare challenges. Evias has a dedicated team that identifies problems and matches them with the best science to bring solutions for the betterment of humanity. The company strongly believes in the boundless potential of science to accomplish remarkable feats when utilized effectively. Currently, there is no publicly available information about Evias's last investment or the last investment investors. Despite this, Evias's commitment to leveraging cutting-edge science for the betterment of healthcare makes it an intriguing prospect for potential investors seeking to make a meaningful impact in the pharmaceutical and healthcare sectors.There is no investment information
No recent news or press coverage available for Evias Pharmaceutical R&D.